M. Karthaus

Statistics

Publications

Citations

305

H-Index

Active since

2014

Affiliations

München Klinik Neuperlach(Current)

West Cancer Center

Helsinn (Switzerland)

M. Karthaus is an author at München Klinik Neuperlach specializing in chemotherapy-induced nausea prevention, antiemetic pharmacology, and pharmacology.

ORCID

Publications per year

2014–2024

Publications

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Matti Aapro, H. S. Rugo, Giada Rizzi et al. · Annals of Oncology · 2014 · 248 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy

Lee Schwartzberg, Eric Roeland, Zoran Andrić et al. · Annals of Oncology · 2018 · 39 citations

Medicine, Oncology, Pharmacology +17

Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)

Arndt Stahler, Andreas Jay Kind, Christine Sers et al. · Clinical Cancer Research · 2024 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

1–3 of 3